Cargando…
Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus
Group A Streptococcus (GAS; Streptococcus pyogenes) is a nearly ubiquitous human pathogen responsible for a significant global disease burden. No vaccine exists, so antibiotics are essential for effective treatment. Despite a lower incidence of antimicrobial resistance than many pathogens, GAS is st...
Autores principales: | Johnson, Anders F., LaRock, Christopher N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601407/ https://www.ncbi.nlm.nih.gov/pubmed/34803985 http://dx.doi.org/10.3389/fmicb.2021.760255 |
Ejemplares similares
-
Playing With Fire: Proinflammatory Virulence Mechanisms of Group A Streptococcus
por: Wilde, Shyra, et al.
Publicado: (2021) -
Detoxification of reactive oxygen species by the hyaluronic acid capsule of group A Streptococcus
por: Wilde, Shyra, et al.
Publicado: (2023) -
Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflammation during bacterial infection
por: Johnson, Anders F., et al.
Publicado: (2023) -
DBA Survivor
por: LaRock, Thomas
Publicado: (2010) -
Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China
por: Liu, Zeliang, et al.
Publicado: (2023)